Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma

PURPOSE: We explored the effect of hepatocyte growth factor (HGF)/Met signaling pathway on nasopharyngeal carcinoma (NPC) cells in vitro and in vivo, and investigated the ability of Met tyrosine kinase inhibitor (TKI) to block HGF-induced biological signaling. EXPERIMENTAL DESIGN: Met TKI inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yuanyuan, Zhang, Jing, Tian, Ying, Xue, Cong, Hu, Zhihuang, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555972/
https://www.ncbi.nlm.nih.gov/pubmed/26345996
http://dx.doi.org/10.2147/DDDT.S85837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4555972/
https://www.ncbi.nlm.nih.gov/pubmed/26345996
http://dx.doi.org/10.2147/DDDT.S85837

Ejemplares similares